GUANGZHOU, China, Nov. 14 /Xinhua-PRNewswire/ -- China Medicine Corporation (OTC Bulletin Board: CHME) (“China Medicine” or “the Company”), a leading developer and distributor of prescription and over the counter pharmaceuticals, traditional Chinese medicines (TCM), nutritional and dietary supplements, and medical devices and medical formulations today announced that the Company will present at the upcoming Roth Capital China Comes to Vegas Conference held November 19 - 21, 2008 at the Wynn Resort and Casino in Las Vegas, Nevada.
The Roth Capital China Comes to Vegas Conference is a three-day event dedicated to Chinese-based, US listed companies. The conference will bring together executives from more than 70 companies with an average market cap of $300 million. Details of China Medicine Corporation’s presentation are as follows:
Date: Friday, November 21, 2008
Time: 11:30 a.m. Pacific Time
Presenter: Senshan Yang, Chief Executive Officer
Venue: Palmer 2 - Track 2
The Wynn Las Vegas
3131 Las Vegas Blvd. South
Las Vegas, NV 89101
During the conference, the Company will be available to meet with analysts and portfolio managers. Participation in the Roth Capital China Comes to Vegas Conference is by invitation only. Further information on the conference can be found at http://www.roth.com .
About China Medicine Corporation
China Medicine Corporation is a leading pharmaceutical company which discovers, develops, and distributes over 2,200 pharmaceutical products in China including prescription and over the counter (“OTC”) drugs, traditional Chinese medicine (“TCM”) products, herbs and dietary supplements. The Company distributes the products to wholesale distributors in 28 provinces, over 300 hospitals, 500 medicine companies, and 1,788 drug stores throughout China. The Company actively develops a number of proprietary products for many uses including oncology, high blood pressure and the removal of toxins from food and animal feeds. For more information visit the Company’s website at http://www.chinamedicinecorp.com .
For more information, please contact:
Company Contact:
Ms. Huizhen Yu
Chief Financial Officer
China Medicine Corporation
Tel: +1-732-438-8866
Email: konzern08@163.com
Investor Relations Contact:
Mr. Crocker Coulson
President
CCG Investor Relations
Tel: +1-646-213-1915 (NY Office)
Email: crocker.coulson@ccgir.com